Manufacturing | Cellgenetherapyreview.com

Refining the molecular blueprint of in vivo CAR-T
Thursday, June 18, 2026
Laboratory management software can’t build a perfectly optimized construct for an in vivo CAR-T cell therapy, but it can make the lives of the scientists doing so ... read more
Ferring debuts U.S. facility to tackle manufacturing bottlenecks
Wednesday, August 13, 2025
Ferring has spared little expense in its efforts to get Adstiladrin to patients, including nearly $500 million in manufacturing investments. read more
The state of CAR-T therapy manufacturing
Wednesday, July 02, 2025
Emerging cell types are broadening the treatment scope of cell therapy, while automation, PAT and strategic partnerships are addressing manufacturing challenges. ... read more
Orchestrating cell and gene therapies
Tuesday, March 25, 2025
An effective orchestration platform is now essential in optimizing processes, fostering collaboration, and ensuring the safe and effective administration of CGTs. These ... read more
Considerations for successful scale-up and viral vector purification
Wednesday, March 19, 2025
To scale up a process, there are several important considerations, starting with the selection of a target batch size. However, process scale-up can encounter challenges.... read more
Is CGT ready for prime time?
Tuesday, March 11, 2025
While challenges with commercial rollouts have been attributed to clinical site readiness, reimbursement coverage and accessibility, CGT drugs to date have predominantly ... read more
Within reach: Bringing cell and gene therapies to under-resourced regions
Tuesday, February 18, 2025
As multiple stakeholders come at the problem from different angles, sustainable global access pathways are beginning to align. From process efficiencies aimed at reining ... read more
The biggest challenges in cell and gene therapy
Monday, February 03, 2025
To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing ... read more
2025 cell and gene challenges: Investment, technology and innovation
Monday, February 03, 2025
To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing ... read more
2025 cell and gene challenges: Thoughts from our editorial board
Monday, February 03, 2025
To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing ... read more
2025 cell and gene challenges: Scalability, supply chain and manufacturing
Monday, February 03, 2025
To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing ... read more
CGT top 10 storylines
Thursday, January 02, 2025
As we head into a new year, it’s time to look back at 2024 and appreciate the tremendous progress made in cell and gene therapy. read more

MHRA’s point-of-care framework for CGTs comes into force
The world-first legislation allow personalized therapies to be prepared in small or individual batches.
Monday, July 28, 2025
CGT players form consortium to deliver automated robotics manufacturing
The 20-month project aims to use novel technologies to deliver a hyper-efficient, fully automated, scalable cell therapy manufacturing platform.
Friday, July 11, 2025
National Resilience shutters plants amid biotech slowdown
The tech-focused CDMO startup revealed plans to consolidate operations, focusing on high-growth segments of advanced therapeutics manufacturing.
Wednesday, June 11, 2025
New coalition launches, aiming to improve CAR-T access
The newly launched CAR T Vision coalition aims is to double the proportion of eligible patients treated with CAR-T cell therapy by 2030.
Friday, May 30, 2025
Astraveus, NecstGen partner on CAR-T therapy manufacturing
The partners will evaluate Astraveus’ benchtop cell factory for the manufacturing of CAR-T therapies.
Tuesday, May 06, 2025

Subscribe to Magazine

Get started here for your complimentary print or digital subscription

Apr/May/Jun 2026 edition now available!
Get started here for your complimentary print or digital subscription
Sign up Now »

BIO International Convention 2026
June 22-25, 2026
8th T-Cell Engager Therapeutics Summit
June 23-25, 2026
AAPS Summer Scientific Forum 2026
July 13-16, 2026